Select the progestin preparation for coadministration
with estrogen for hormone replacement therapy that
does not counteract the beneficial effect of the latter
on lipid profile due to lack of androgenic activity:
A. Micronized oral progesterone
B. Norethindrone
C. Lynestrenol
D. Medroxyprogesterone acetate (p. 281-282)
with estrogen for hormone replacement therapy that
does not counteract the beneficial effect of the latter
on lipid profile due to lack of androgenic activity:
A. Micronized oral progesterone
B. Norethindrone
C. Lynestrenol
D. Medroxyprogesterone acetate (p. 281-282)